Drug Approval | May 14, 2022
Zydus launches Bemdac to treat LDL-Cholesterol
It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins
It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data management teams
RNA extraction free kit to deliver results in just 45 minutes
The campaign will be available in nine Indian languages namely Hindi, English, Odia, Marathi, Tamil, Telugu, Kannada, Malayalam and Bengali
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
The aim is to bring patient consent tools in a digital format in addition to a paper format which is not just a need of the current times but also a way forward
With the introduction of this device, Alkem is entering the core inhalation therapeutics and envisaging that the drug will reach the lungs effectively in each inhalation with added patient awareness and adherence programmes
It is the first hospital in the country to achieve the significant milestone of completing over 2600 robotic surgeries for treating patients with prostate, kidney and urinary bladder cancer
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
Subscribe To Our Newsletter & Stay Updated
